Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing

Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing

The spectrum of neurodegenerative diseases known today is quite extensive. The complexities of their research and treatment lie not only in their diversity. Even many years of struggle and narrowly focused research on common pathologies such as Alzheimer’s, Parkinson’s, and other brain diseases have...

Full description

Bibliographic Details
Main Authors:	Vladlena S. Makeeva, Nadezhda S. Dyrkheeva, Olga I. Lavrik, Suren M. Zakian, Anastasia A. Malakhova
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	International Journal of Molecular Sciences
Subjects:	Huntington’s disease drug target PARP1 inhibitor drug repurposing
Online Access:	https://www.mdpi.com/1422-0067/24/23/16798

Similar Items

An unsupervised computational pipeline identifies potential repurposable drugs to treat Huntington's disease and multiple sclerosis
by: Luca Menestrina, et al.
Published: (2022-12-01)

Repurposing antifungal drugs for cancer therapy
by: Ningna Weng, et al.
Published: (2023-06-01)

Existing Evidence for the Repurposing of PARP-1 Inhibitors in Rare Demyelinating Diseases
by: Marianna Mekhaeil, et al.
Published: (2022-01-01)

Pathway2Targets: an open-source pathway-based approach to repurpose therapeutic drugs and prioritize human targets
by: Mauri Dobbs Spendlove, et al.
Published: (2023-09-01)

Immune Modulatory Effects of Molecularly Targeted Therapy and Its Repurposed Usage in Cancer Immunotherapy
by: Tiancheng Zhang, et al.
Published: (2022-08-01)

Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
by: Noemi Cowan, et al.
Published: (2015-08-01)

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?
by: Pan Pantziarka, et al.
Published: (2018-06-01)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
by: Daniele Parisi, et al.
Published: (2020-01-01)

Drug Repurposing in the Chemotherapy of Infectious Diseases
by: Amal Hamid, et al.
Published: (2024-01-01)

Drug repurposing and prediction of multiple interaction types via graph embedding
by: E. Amiri Souri, et al.
Published: (2023-05-01)

Repurposed Drugs in Gastric Cancer
by: Diana Araújo, et al.
Published: (2022-12-01)

Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis
by: Bernardo Pereira Moreira, et al.
Published: (2022-02-01)

Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures
by: Andrés Pizzorno, et al.
Published: (2019-01-01)

In Vitro Drug Repurposing: Focus on Vasodilators
by: Eduarda Ribeiro, et al.
Published: (2023-02-01)

Drug repurposing: a systematic review on root causes, barriers and facilitators
by: Nithya Krishnamurthy, et al.
Published: (2022-07-01)

Advancements in Drug Repurposing: Examples in Psychiatric Medications
by: Ryo Okuyama
Published: (2023-07-01)

Prospects for repurposing CNS drugs for cancer treatment
by: Mohamed Abdelaleem, et al.
Published: (2019-04-01)

Melatonin as a Repurposed Drug for Melanoma Treatment
by: Rachana Pathipaka, et al.
Published: (2023-01-01)

Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway
by: Anisha S. Jain, et al.
Published: (2021-10-01)

Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
by: Christina Pfab, et al.
Published: (2021-06-01)

PARP inhibitors combined with radiotherapy: are we ready?
by: Chen Sun, et al.
Published: (2023-10-01)

An Overview of Repurposed Drugs for Potential COVID-19 Treatment
by: Kamini Govender, et al.
Published: (2022-11-01)

Editorial: Biological aspects of targeted drug discovery: Development of novel targets and/or chemotherapies, and drug repurposing
by: Rajkumar Singh Kalra, et al.
Published: (2022-12-01)

Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
by: Mithun Rudrapal, et al.
Published: (2022-12-01)

Molecular targets and system biology approaches for drug repurposing against SARS-CoV-2
by: Rahul Kunwar Singh, et al.
Published: (2020-11-01)

Repurposing drugs for solid tumor treatment: focus on immune checkpoint inhibitors
by: Qingxu Liu, et al.
Published: (2023-11-01)

Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
by: Joana M. O. Santos, et al.
Published: (2021-10-01)

Mifepristone Repurposing in Treatment of High-Grade Gliomas
by: Monserrat Llaguno-Munive, et al.
Published: (2021-02-01)

Editorial: Drug Repurposing
by: Pan Pantziarka, et al.
Published: (2019-07-01)

Multi-Targeted Approaches and Drug Repurposing Reveal Possible SARS-CoV-2 Inhibitors
by: Khalid Mashay Alanazi, et al.
Published: (2021-12-01)

Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders
by: Sweta Shah, et al.
Published: (2021-12-01)

Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit?
by: Anna V. Wojcicki, et al.
Published: (2020-02-01)

Repurposing Anti-Cancer Drugs for COVID-19 Treatment
by: Borcherding N, et al.
Published: (2020-11-01)

Sertaconazole-repurposed nanoplatform enhances lung cancer therapy via CD44-targeted drug delivery
by: Ruolan Liu, et al.
Published: (2023-07-01)

Pharmacological Efficacy of Repurposing Drugs in the Treatment of Prostate Cancer
by: Tânia Lourenço, et al.
Published: (2023-02-01)

Drug combination and repurposing for cancer therapy: the example of breast cancer
by: Ana Salomé Correia, et al.
Published: (2021-01-01)

Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy
by: Michel Montalvo-Casimiro, et al.
Published: (2020-11-01)

COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
by: Mario Roberto Senger, et al.

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
by: Norihiro Sakai, et al.
Published: (2023-08-01)

Drug repurposing with network reinforcement
by: Yonghyun Nam, et al.
Published: (2019-07-01)